Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Abstract 18: Predictive value of BRCA1 haplotype for trabectedin efficacy in patients with advanced soft-tissue sarcoma.

Audrey Laroche-Clary, Vanessa Chaire, Valérie Le Morvan, Agnès Neuville, Sébastien Salas, François Bertucci, Philippe Pourquier, Antoine Italiano

Cancer Res (2013) 73 (8_Supplement): 18.

https://doi.org/10.1158/1538-7445.AM2013-18

Published: 15 April 2013

View article titled, Abstract 18: Predictive value of BRCA1 haplotype for trabectedin efficacy in patients with advanced soft-tissue sarcoma.

Journal Articles

Abstract 858: ERK2 rather than ERK1 contributes to EMT and metastatic potential in triple-negative breast cancer.

Chandra Bartholomeusz, Hitomi Saso, Ali Dadbin, Hiroko Masuda, Takahiro Kogawa, Steven Van Laere, François Bertucci, Gabriel N. Hortobagyi, Naoto T. Ueno

Cancer Res (2013) 73 (8_Supplement): 858.

https://doi.org/10.1158/1538-7445.AM2013-858

Published: 15 April 2013

View article titled, Abstract 858: ERK2 rather than ERK1 contributes to EMT and metastatic potential in triple-negative breast cancer.

Journal Articles

Abstract 328: An integrated analysis of three distinct IBC/non-IBC Affymetrix gene expression data sets to study the transcriptional heterogeneity both between IBC and non-IBC and within IBC

Steven J. Van Laere, Naoto Ueno, Pascal Finetti, Peter B. Vermeulen, Anthony Lucci, Daniel Birnbaum, Fredika Robertson, Takayuki Iwamoto, Peter Van Dam, Wendy Woodward, Patrice Viens, Luc Y. Dirix, James Reuben Reuben, François Bertucci

Cancer Res (2011) 71 (8_Supplement): 328.

https://doi.org/10.1158/1538-7445.AM2011-328

Published: 15 April 2011

View article titled, Abstract 328: An integrated analysis of three distinct IBC/non-IBC Affymetrix gene expression data sets to study the transcriptional heterogeneity both between IBC and non-IBC and within IBC

Journal Articles

Abstract 3427: A core invasiveness gene signature reveals reduced EMT in samples from patients with IBC, potentially regulated by decreased EGFR- and TGFb-signaling

Melike Marsan, Ridha Limame, Katrien François, François Bertucci, Nato Ueno, Filip Lardon, Patrick Pauwels, Peter Van Dam, Peter B. Vermeulen, Luc Y. Dirix, Steven J. Van Laere

Cancer Res (2011) 71 (8_Supplement): 3427.

https://doi.org/10.1158/1538-7445.AM2011-3427

Published: 15 April 2011

View article titled, Abstract 3427: A core invasiveness gene signature reveals reduced EMT in samples from patients with IBC, potentially regulated by decreased EGFR- and TGFb-signaling

Journal Articles

Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature

Emmanuelle Charafe-Jauffret, Christophe Ginestier, Flora Iovino, Julien Wicinski, Nathalie Cervera, Pascal Finetti, Min-Hee Hur, Mark E. Diebel, Florence Monville, Julie Dutcher, Marty Brown, Patrice Viens, Luc Xerri, François Bertucci, Giorgio Stassi, Gabriela Dontu, Daniel Birnbaum, Max S. Wicha

Cancer Res (2009) 69 (4): 1302–1313.

https://doi.org/10.1158/0008-5472.CAN-08-2741

Published: 12 February 2009

View article titled, Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature

Includes: Supplementary data

Journal Articles

Sixteen–Kinase Gene Expression Identifies Luminal Breast Cancers with Poor Prognosis

Pascal Finetti, Nathalie Cervera, Emmanuelle Charafe-Jauffret, Christian Chabannon, Colette Charpin, Max Chaffanet, Jocelyne Jacquemier, Patrice Viens, Daniel Birnbaum, François Bertucci

Cancer Res (2008) 68 (3): 767–776.

https://doi.org/10.1158/0008-5472.CAN-07-5516

Published: 01 February 2008

View article titled, Sixteen–Kinase Gene Expression Identifies Luminal Breast Cancers with Poor Prognosis

Includes: Supplementary data

Journal Articles

Integrated Profiling of Basal and Luminal Breast Cancers

José Adélaïde, Pascal Finetti, Ismahane Bekhouche, Laetitia Repellini, Jeannine Geneix, Fabrice Sircoulomb, Emmanuelle Charafe-Jauffret, Nathalie Cervera, Jérôme Desplans, Daniel Parzy, Eric Schoenmakers, Patrice Viens, Jocelyne Jacquemier, Daniel Birnbaum, François Bertucci, Max Chaffanet

Cancer Res (2007) 67 (24): 11565–11575.

https://doi.org/10.1158/0008-5472.CAN-07-2536

Published: 18 December 2007

View article titled, Integrated Profiling of Basal and Luminal Breast Cancers

Includes: Supplementary data

Journal Articles

Gene Expression Profiling Shows Medullary Breast Cancer Is a Subgroup of Basal Breast Cancers

François Bertucci, Pascal Finetti, Nathalie Cervera, Emmanuelle Charafe-Jauffret, Emilie Mamessier, José Adélaïde, Stéphane Debono, Gilles Houvenaeghel, Dominique Maraninchi, Patrice Viens, Colette Charpin, Jocelyne Jacquemier, Daniel Birnbaum

Cancer Res (2006) 66 (9): 4636–4644.

https://doi.org/10.1158/0008-5472.CAN-06-0031

Published: 01 May 2006

View article titled, Gene Expression Profiling Shows Medullary Breast Cancer Is a Subgroup of Basal Breast Cancers

Includes: Supplementary data

Journal Articles

Definition of basal-like breast tumors: Validation of new protein markers

Emmanuelle A. Charafe-Jauffret, Florence Monville, Pascal Finetti, Nathalie Cervera, Jeanine Geneix, Jocelyne Jacquemier, François Bertucci, Patrice Viens, Daniel Birnbaum

Cancer Res (2006) 66 (8_Supplement): 845.

Published: 15 April 2006

View article titled, Definition of basal-like breast tumors: Validation of new protein markers

Journal Articles

Identification and validation of a genomic predictor to distinguish classes of patients with distinct outcomes among poor prognosis breast tumors after anthracycline-based adjuvant therapy

François Bertucci, Nathalie Borie, Thomas Bachelot, Henri Roché, Agnès Martinec, Stéphane Debono, Fabienne Hermitte, Jocelyne Jacquemier, Isabelle Treilleux, Gaetan Macgrogan, Anne-Laure Martin, Jean Genève, Vincent Fert, Daniel Birnbaum, Patrice Viens

Cancer Res (2006) 66 (8_Supplement): 841.

Published: 15 April 2006

View article titled, Identification and validation of a genomic predictor to distinguish classes of patients with distinct outcomes among poor prognosis breast tumors after anthracycline-based adjuvant therapy

Journal Articles

Development of the Breast Cancer ProfileChip™, a new diagnostic device to refine the molecular classification and improve the clinical management of breast cancer

Nicolas Maroc, Alane Koki, Stéphane Deraco, Juan Manuel Cabrera, Albane Lamy De La Chapelle, Olivier Biglia, Fabienne Hermitte, Stéphane Debono, Daniel Birnbaum, François Bertucci, Nathalie Borie

Cancer Res (2005) 65 (9_Supplement): 735.

Published: 01 May 2005

View article titled, Development of the Breast Cancer Profile<em>Chip</em>™, a new diagnostic device to refine the molecular classification and improve the clinical management of breast cancer

Journal Articles

Utilization of microarray technology to refine molecular classes and improve clinical management of breast cancer

Patrice Viens, Nathalie Borie, François Bertucci, Gaetan Macgrogan, Jocelyne Jacquemier, Veronique Picot, Thomas Bachelot, Isabelle Treilleux, Michele Longy, Stéphane Deraco, Simone Mathoulin, Stéphane Debono, Fabienne Hermitte, Daniel Birnbaum, Alane T. Koki

Cancer Res (2005) 65 (9_Supplement): 618.

Published: 01 May 2005

View article titled, Utilization of microarray technology to refine molecular classes and improve clinical management of breast cancer

Journal Articles

Gene Expression Profiling Identifies Molecular Subtypes of Inflammatory Breast Cancer

François Bertucci, Pascal Finetti, Jacques Rougemont, Emmanuelle Charafe-Jauffret, Nathalie Cervera, Carole Tarpin, Catherine Nguyen, Luc Xerri, Rémi Houlgatte, Jocelyne Jacquemier, Patrice Viens, Daniel Birnbaum

Cancer Res (2005) 65 (6): 2170–2178.

https://doi.org/10.1158/0008-5472.CAN-04-4115

Published: 21 March 2005

View article titled, Gene Expression Profiling Identifies Molecular Subtypes of Inflammatory Breast Cancer

Journal Articles

Protein Expression Profiling Identifies Subclasses of Breast Cancer and Predicts Prognosis

Jocelyne Jacquemier, Christophe Ginestier, Jacques Rougemont, Valérie-Jeanne Bardou, Emmanuelle Charafe-Jauffret, Jeannine Geneix, José Adélaïde, Alane Koki, Gilles Houvenaeghel, Jacques Hassoun, Dominique Maraninchi, Patrice Viens, Daniel Birnbaum, François Bertucci

Cancer Res (2005) 65 (3): 767–779.

https://doi.org/10.1158/0008-5472.767.65.3

Published: 10 February 2005

View article titled, Protein Expression Profiling Identifies Subclasses of Breast Cancer and Predicts Prognosis

Includes: Supplementary data

Journal Articles

Gene Expression Profiling for Molecular Characterization of Inflammatory Breast Cancer and Prediction of Response to Chemotherapy

François Bertucci, Pascal Finetti, Jacques Rougemont, Emmanuelle Charafe-Jauffret, Valéry Nasser, Béatrice Loriod, Jacques Camerlo, Rebecca Tagett, Carole Tarpin, Gilles Houvenaeghel, Catherine Nguyen, Dominique Maraninchi, Jocelyne Jacquemier, Rémi Houlgatte, Daniel Birnbaum, Patrice Viens

Cancer Res (2004) 64 (23): 8558–8565.

https://doi.org/10.1158/0008-5472.CAN-04-2696

Published: 01 December 2004

View article titled, Gene Expression Profiling for Molecular Characterization of Inflammatory Breast Cancer and Prediction of Response to Chemotherapy

Includes: Supplementary data

NARROW

Abstract 18: Predictive value of BRCA1 haplotype for trabectedin efficacy in patients with advanced soft-tissue sarcoma.

Abstract 858: ERK2 rather than ERK1 contributes to EMT and metastatic potential in triple-negative breast cancer.

Abstract 328: An integrated analysis of three distinct IBC/non-IBC Affymetrix gene expression data sets to study the transcriptional heterogeneity both between IBC and non-IBC and within IBC

Abstract 3427: A core invasiveness gene signature reveals reduced EMT in samples from patients with IBC, potentially regulated by decreased EGFR- and TGFb-signaling

Breast Cancer Cell Lines Contain Functional Cancer Stem Cells with Metastatic Capacity and a Distinct Molecular Signature

Sixteen–Kinase Gene Expression Identifies Luminal Breast Cancers with Poor Prognosis

Integrated Profiling of Basal and Luminal Breast Cancers

Gene Expression Profiling Shows Medullary Breast Cancer Is a Subgroup of Basal Breast Cancers

Definition of basal-like breast tumors: Validation of new protein markers

Identification and validation of a genomic predictor to distinguish classes of patients with distinct outcomes among poor prognosis breast tumors after anthracycline-based adjuvant therapy

Development of the Breast Cancer ProfileChip™, a new diagnostic device to refine the molecular classification and improve the clinical management of breast cancer

Utilization of microarray technology to refine molecular classes and improve clinical management of breast cancer

Gene Expression Profiling Identifies Molecular Subtypes of Inflammatory Breast Cancer

Protein Expression Profiling Identifies Subclasses of Breast Cancer and Predicts Prognosis

Gene Expression Profiling for Molecular Characterization of Inflammatory Breast Cancer and Prediction of Response to Chemotherapy

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only